Dr Craig Turner is a Partner and UK Chartered and European Patent Attorney in the Chemistry, Biotechnology and Pharmaceutical patents department. Craig’s key client base are large corporations in the oil and gas, pharmaceuticals and biotechnology industry sectors.
The Legal 500 2017 edition has now been published and we are delighted that the firm has once again been ranked as a leading firm for both patents and trade marks, and that our level of service was recognised as “outstanding”. The editorial sections for each of our entries in the directory are reproduced below: “A.A. Thornton & Co.’s level… Read more »
In response to an opposition by chemicals company BASF, Craig Turner, a partner in our Chemistry, Biotechnology and Pharmaceutical patents team, successfully defended Lycored’s European patent which protects their unique lycopene formulation, used for providing stable red colouring for foods, cosmetics and pharmaceuticals. Longstanding client Lycored are a market-leader in the development and supply of research-based,… Read more »
We are delighted to announce that Partners of the firm, Ian Gill and Craig Turner, have been nominated for inclusion in the publication, Who’s Who Legal: Patents 2016 (wwwwhoswholegal.com). Nominees for the publication are selected based upon comprehensive, independent survey work with both general counsel and private practice lawyers worldwide. Only specialists who have met… Read more »
Swiss Biotech Day 2018, Basel, Switzerland Patent Attorneys Dr Craig Turner and Julie Barrett- Major represented the firm at the Swiss Biotech Day 2018, in Basel, Switzerland, on 3 May 2018. According to European Biotechnology Magazine, “with more than 600 senior executives from the Swiss life science industry and from across Europe the annually held was as popular as… Read more »
Patent Attorneys Geoff Hussey, Craig Turner, Alex Bone and Leonita Paulraj are attending CPhI’s 7th Annual Pharma IPR Conference in Mumbai, India from 7th-9th March. Craig and Geoff will also be speaking about the implications of Brexit on Indian pharma companies on the 8th March. CPhI’s 7th Annual Pharma IPR Conference is a leading platform… Read more »